Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 crossover MRI contrast study of gadoquatrane vs macrocyclic GBCAs (non-CNS)
jRCT2011230025Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2023
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of gadoquatrane in None (2 arms), sponsored by Bayer. Primary endpoints: Contrast enhancement, Lesion delineation and 1 more. Started Aug 2023; status: completed.
02
Drugs
gadoquatrane
Beyond the preview
Go deeper on jRCT2011230025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011230025.